Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Wnt agonist 1 in Wnt–GPX4 Assay Design
2026-08-23
Wnt agonist 1 (BML-284) offers a defined pharmacological input for studying β-catenin–TCF signaling and its possible relationship to GPX4-linked platinum resistance. This article focuses on causal assay design, evidence boundaries, and translational limitations rather than repeating a standard activation protocol.
-
40-Hz Flicker and Retinal Amyloid Clearance
2026-08-22
A 2026 mouse study reports that 40-Hz light flicker enhances retinal amyloid-β clearance through regulation of MHC-II-positive microglia. The work connects sensory stimulation with immune-mediated waste removal and uses minocycline inhibition to test whether microglial activity is required for improved retinal function.
-
Tetracycline: From Ribosome Tool to Translation
2026-08-21
Tetracycline is more than a routine antibiotic selection reagent. This thought-leadership article examines its ribosomal mechanism, experimental value, translational boundaries, and strategic use alongside mechanistic cancer research such as LKB1-driven senescence in lung adenocarcinoma.
-
Fingolimod and the Next Frontier of Immune Trafficking
2026-08-20
Fingolimod (FTY720) offers translational researchers more than an established multiple sclerosis mechanism: it is a controlled perturbation of lymphocyte positioning. When considered alongside magnetic bispecific nano-antibody platforms for in vivo CAR-T-mimicking cell generation, its value lies in helping researchers separate immune-cell availability, tumor infiltration, and per-cell antitumor function.
-
Cyclosporin A: From Mechanism to Translation
2026-08-20
Cyclosporin A is more than a calcineurin inhibitor. Its cyclophilin-dependent biology, membrane behavior, and variant-specific mitochondrial activity provide a practical framework for designing more predictive immunology and mitochondrial studies.
-
KN-62 Workflows for CaMKII Signaling
2026-08-19
KN-62 enables controlled interrogation of CaMKII-dependent calcium signaling in secretion, metabolism, and cell-cycle assays. This guide pairs practical dosing and troubleshooting with an orthogonal channel-pharmacology framework drawn from neuronal electrophysiology.
-
Sulfo-Cy3 NHS Ester in Vascular Translation
2026-08-19
Translational vascular research increasingly depends on methods that preserve biomolecular behavior while making complex mechanisms visible. This article examines how Sulfo-Cy3 NHS ester, a hydrophilic fluorescent dye for amino-group labeling, can support mechanistic studies of the AIBP–LRP2–HDL–miR-223–CXCR4 axis and help researchers build more reproducible workflows from conjugation chemistry to vascular phenotyping.
-
N-Formimidoyl Thienamycin: Comparative Antibacterial Evidenc
2026-08-18
This 1982 study evaluated N-formimidoyl thienamycin (MK0787) against a broad panel of resistant clinical isolates and compared it with several contemporary β-lactam antibiotics. Its strongest contributions were the demonstration of activity against Pseudomonas aeruginosa and Acinetobacter spp., bactericidal effects against gram-negative isolates, and apparent independence from β-lactamase production.
-
MEK1/2, c-Myc, and TERT in Human Stem Cells
2026-08-18
This preprint identifies a regulatory connection in which MEK1/2–ERK signaling and c-Myc:MAX cooperate to maintain TERT transcription in human embryonic stem cells by limiting PRC2-associated repression. Its findings link kinase signaling, transcription-factor occupancy, and opposing H3K27 methylation and acetylation states at the TERT promoter, offering a mechanistic framework for studying telomere regulation in normal pluripotent cells.
-
Caspofungin Workflows for Resistant Candida
2026-08-17
Build resistance-aware Candida assays around Caspofungin, a lipopeptide antifungal drug that targets β-(1,3)-D-glucan production. This guide connects susceptibility testing with delayed-treatment models, comparator design, and practical troubleshooting for translational antifungal therapeutics research.
-
Ivermectin: Mechanism, Evidence, and Research Limits
2026-08-17
Ivermectin is a broad-spectrum anti-parasitic agent used in approved therapies for selected nematode and ectoparasite infections. This article separates established pharmacology and product specifications from unsupported extensions, including claims about cancer or COVID-19.
-
Doxycycline for Hydrogel Mechanobiology Research
2026-08-16
Learn how to use Doxycycline as a controlled perturbation in 3D hydrogel assays that connect matrix remodeling, cell motion, and differentiation. This workflow also separates antimicrobial, antiproliferative, and metalloproteinase-related effects from genuine nuclear mechanotransduction signals.
-
Sex Differences in Angiotensin II Hypertension
2026-08-15
Xue, Pamidimukkala, and Hay used telemetry in conscious mice to show that chronic angiotensin II produces substantially greater hypertension in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further implicated sex hormones, altered autonomic regulation, and sympathetic activity in the divergent blood-pressure responses.
-
Galectin-1, FIP200, and Autophagy in Hepatic Steatosis
2026-08-14
The reference study identifies galectin-1 as an upstream driver of hepatic steatosis and insulin resistance through direct interference with the autophagy scaffold FIP200. By combining mouse models, proteomics, biochemical binding analysis, structural mapping, and interaction-disrupting mutations, the work defines the Gal-1–FIP200 axis as a mechanistic target in metabolic liver disease research.
-
Cinoxacin: In Vitro Antibacterial Study Findings
2026-08-14
The 1975 study by Lumish and Norden established a systematic in vitro profile for Cinoxacin, combining susceptibility testing, disk diffusion, bactericidal assays, and serial-passage resistance experiments. Its findings defined strong activity against many aerobic gram-negative bacilli while identifying limited activity against Pseudomonas aeruginosa and Gram-positive isolates, creating a practical foundation for urinary tract infection research and later quinolone comparisons.